Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 49 companies made new 52-week lows.
DYAI: Dapibus on the Menu
By John Vandermosten, CFA
NASDAQ:DYAI
READ THE FULL DYAI RESEARCH REPORT
Dyadic International: Q2 Earnings Insights
Dyadic International (NASDAQ:DYAI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Dyadic International Q2 EPS $(0.12) Misses $(0.09) Estimate, Sales $628.553K Miss $1.84M Estimate; Cash Position $15.7M
Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year.
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Dyadic International Q1 EPS $(0.09) Misses $(0.08) Estimate, Sales $648.43K Up From $460.52K YoY
Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 25 percent increase over losses of $(0.12) per share
India Funds Affordable COVID-19 Vaccine Candidate Using Dyadic’s Platform
Dyadic International Inc’s (NASDAQ:DYAI) licensee, Epygen Biotech PVD, LTD., has received funding from the Government of India to advance an affordable COVID-19…
Dyadic InternationalLicensee, Epygen Biotech PVD, LTD., Receives Funding From Indian Government To Advance COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2 antigen
Funding earmarked to support Phase 1 and 2